CTOs on the Move

Health Communication Connection

www.healthcommunication.info

 
Health Communication Connection is a Vienna, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Ambry Genetics

Ambry Genetics is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Sinai Residences

Sinai Residences is a retirement community in Boca Raton that offers luxurious surroundings and a culture of sophistication. They provide top-notch independent and assisted living, memory care, rehab, and skilled nursing services on site.

Medical Center of McKinney

Medical Center of McKinney (MCM) is a growing 260-bed hospital with a 90-year history of serving the health care needs of McKinney and the surrounding communities. Over the past several years, MCM has strengthened its medical foundations by adding two new surgical robots, a newly remodeled labor and delivery suites, a Level III Neonatal Intensive Care Unit (NICU) and an advanced biplane Catheterization (cath) lab to treat heart rhythm disorders. Medical Center of McKinney will be expanding its services to the community with the addition of a new off-campus emergency department at 380 & Custer in 2015. 

Ambulatory Surgical Centres Canada Corporation

Ambulatory Surgical Centres Canada Corporation is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.